Company Overview and News

 
Fura Closes Private Placement Financing and Announces Board Appointment

2018-09-17 globenewswire
TORONTO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Fura Gems Inc. (“Fura” or the “Company”) (TSXV: FURA) (OTC: FUGMF) (FRA: BJ43), a new gemstone mining and marketing company with emerald and ruby assets in Colombia and Mozambique, respectively, has closed, on a fully subscribed basis, its previously announced private placement of common shares (the “Financing”). The Company issued 25,117,569 common shares pursuant to the Financing at a price of $0.
MUS CPNFD FUGMF

 
Mustang Resources eyes first cash flow from world-class vanadium-graphite project in 2019

2018-09-17 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) is fast-tracking its world-class Caula Vanadium-Graphite Project in Mozambique, with first cash flows targeted for H2 of 2019 from trial mining operations.
MUS SRHYY SYR SYAAF

 
Mustang Resources drilling extends graphite vanadium resource

2018-09-06 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has completed, ahead of schedule, its feasibility study drilling program on the Caula Vanadium-Graphite Project in Mozambique.
MUS SRHYY SYR SYAAF

 
Mustang Resources to outline shift in focus to battery metals at Proactive CEO Sessions

2018-09-03 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) is shifting its focus to the key battery metals of vanadium and graphite and this process involves a proposed name change to New Energy Minerals Ltd (ASX:NXE).
MUS SRHYY SYR FUGMF SYAAF

18
Graphite Miners News For The Month Of August 2018

2018-08-28 seekingalpha - 1
Graphite market news - "The graphite electrode market is expected to sustain its growth momentum in the current year (2018-19) as the demand-supply gap is expected to widen."
GRXXF URA SRHYY BKR BSSMF LMRMF URLNF URRE ZEYYF GPHEF RNU ABGPF GPHOF BSM LLG APMFD NSRC KBBRF CYLYF AMVMF WKT IMYSY FMS GRPH TON ZENYF DNI BKT MUS IMYSF DMNKF SYR GLKIF LMR NGPHF TLG ALP LEMIF GLK WWR ZEN FSRCY SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF CZSVF

 
Mustang Resources given funding discretion after Arena Investors agrees to amendments

2018-08-15 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has been given funding discretion after major institutional investor Arena Investors LP agreed to amend key approvals and waivers of a $19.95 million investment agreement.
MUS FUGMF

 
Fura Announces Private Placement

2018-08-14 globenewswire
TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Fura Gems Inc. (“Fura” or the “Company”) (TSXV: FURA) (OTC: FUGMF) (FRA: BJ43), a new gemstone mining and marketing company with emerald and ruby assets in Colombia and Mozambique, respectively, intends to complete a private placement offering of up to 25 million common shares of the Company at a price of CAD$0.40 per share for gross proceeds of up to CAD$10 million (the “Offering”).
MUS FUGMF

 
Mustang Resources secures $2.4 million for vanadium graphite project

2018-08-13 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has secured commitments to raise $2.4 million from sophisticated and institutional investors in a placement of shares priced at 1.374 cents.
MUS

 
Mustang Resources granted trading halt ahead of capital raising news

2018-08-09 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has been granted a trading halt by the ASX pending news of a capital raising placement.
MUS

 
Mustang Resources begins feasibility drilling at Caula Vanadium-Graphite Project

2018-08-08 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has begun a drilling program at its Caula project in northern Mozambique, with over 4,000 metres planned for completion this quarter.
MUS SRHYY SYR SYAAF

 
Mustang Resources enters trading halt ahead of an update

2018-07-30 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has been granted a trading halt by the ASX pending information regarding clarification of a published report.
MUS

24
Graphite Miners News For The Month Of July 2018

2018-07-28 seekingalpha - 4
Graphite spot prices were flat in July. AMR - "Graphite prices high – batteries and electrodes could push H2 2018 prices even higher."
GRXXF URA SRHYY BKR BSSMF LMRMF URLNF URRE ZEYYF GPHEF IAG RNU ABGPF GPHOF BSM LLG APMFD NSRC KBBRF CYLYF AMVMF WKT IMYSY FMS GRPH TON ZENYF DNI BKT MUS IMYSF DMNKF SYR GLKIF LMR NGPHF TLG ALP LEMIF GLK WWR ZEN FSRCY SYAAF KNL ECORF SVM NSRCF MGPHF URI FCSMF CZSVF

 
Mustang Resources shifts focus to graphite and vanadium

2018-07-26 proactiveinvestors.com.au
Vanadium is another metal that has in the past received little attention but has undergone a huge price surge over the past two years, as China tightens its standards around the strength of steel and the battery revolution continues.
MUS

 
Fura to Acquire Additional Ruby Licence in Mozambique

2018-07-26 globenewswire
TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- Fura Gems Inc. (“Fura” or the “Company”) (TSXV:FURA) (OTC:FUGMF) (FRA:BJ43), a new gemstone mining and marketing company with emerald and ruby assets in Colombia and Mozambique, respectively, is pleased to announce it has entered into a share purchase agreement pursuant to which the Company will acquire a 100% interest in ruby prospecting licence No. 5572L (the “Licence”) in the Montepuez District of Cabo Delgado province in Mozambique (the “Acquisition”).
MUS FUGMF

 
Mustang Resources shares ride higher after fourfold increase in graphite resource

2018-07-24 proactiveinvestors.com.au
Mustang Resources Ltd (ASX:MUS) has taken another key step towards development with the completion of an upgraded graphite resource for its Caula Vanadium-Graphite Project in Mozambique.
MUS FUGMF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:MUS / MUSTANG RESOURCES LIMITED on message board site Silicon Investor.

Music Jukebox Music Jukebox Music Jukebox Muslims Gone Mad Muslims Gone Mad Muslims Gone Mad
Free Music u0026 Video Over The Internet Free Music u0026 Video Over The Internet Free Music u0026 Video Over The Internet INCOME TAX Must GO !! INCOME TAX Must GO !! INCOME TAX Must GO !!
Nostradamus: Predictions Nostradamus: Predictions Nostradamus: Predictions MUSIC STOCKS: HIGH-TECH AND INTERNET- Winners and losers. MUSIC STOCKS: HIGH-TECH AND INTERNET- Winners and losers. MUSIC STOCKS: HIGH-TECH AND INTERNET- Winners and losers.
(PAMT) Is it really the sweet sound of music or a fleecing t (PAMT) Is it really the sweet sound of music or a fleecing t (PAMT) Is it really the sweet sound of music or a fleecing t Live Music Live Music Live Music
Beta Music Group, Inc. Beta Music Group, Inc. Beta Music Group, Inc. Some gun controls ,,a must Some gun controls ,,a must Some gun controls ,,a must